Mios, France

Geraldine San Jose

This inventor holds 1 USPTO granted patent. Top assignees: George Mason University, St. Jude Children's Research Hospital, The George Washington University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geraldine San Jose. Retrieved from https://idiyas.com/inventor/geraldine-san-jose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Geraldine San Jose: Innovator in Pharmaceutical Compounds

Introduction

Geraldine San Jose is a notable inventor based in Mios, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit specific enzymes. Her work has implications for treating various diseases, showcasing her innovative spirit and dedication to scientific advancement.

Latest Patents

Geraldine holds a patent for "Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase." This invention is particularly effective in inhibiting Dxr in Mycobacterium tuberculosis (Mtb). The compounds she developed are represented by general formulas (I) and (II), highlighting her expertise in medicinal chemistry.

Career Highlights

Throughout her career, Geraldine has worked with prestigious institutions, including Washington University and George Mason University. Her experience in these research environments has allowed her to collaborate with leading scientists and contribute to groundbreaking research.

Collaborations

Geraldine has collaborated with esteemed colleagues, including Helena I. Boshoff and Cynthia Dowd. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Geraldine San Jose is a pioneering inventor whose work in pharmaceutical compounds demonstrates her commitment to innovation and scientific progress. Her contributions are vital in the ongoing fight against diseases, particularly those caused by Mycobacterium tuberculosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…